NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/12/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,634.29 mln
Float14.14 mln
Earnings Date05/08/2026
Relative Strength
9
/ 100
Severely lagging
Debt / Equity
-0.26
Negative equity
ROE
-33.58
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, makes tools that help scientists detect and measure proteins in the blood to identify diseases at an early stage. Its flagship ARGO system automates this process with exceptional sensitivity, supporting research across fields such as cancer, neurology, and immunology. The company serves universities, drug developers, and research labs across North America, Europe, the Middle East, and Asia Pacific.
